Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer
Vaishampayan, Ulka N., Keessen, Marianne, Dreicer, Robert, Heath, Elisabeth I., Buchler, Tomas, Árkosy, Péter F., Csöszi, Tibor, Wiechno, Pawel, Kopyltsov, Evgeny, Orlov, Sergey V., Plekhanov, Alexey, Smagina, Maria, Varlamov, Sergei, Shore, Neal D.
Published in European journal of cancer (1990) (01.05.2024)
Published in European journal of cancer (1990) (01.05.2024)
Get full text
Journal Article
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Martín, Miguel, Zielinski, Christoph, Ruiz-Borrego, Manuel, Carrasco, Eva, Ciruelos, Eva M., Muñoz, Montserrat, Bermejo, Begoña, Margelí, Mireia, Csöszi, Tibor, Antón, Antonio, Turner, Nicholas, Casas, María I., Morales, Serafín, Alba, Emilio, Calvo, Lourdes, de la Haba-Rodríguez, Juan, Ramos, Manuel, Murillo, Laura, Santaballa, Ana, Alonso-Romero, José L., Sánchez-Rovira, Pedro, Corsaro, Massimo, Huang, Xin, Thallinger, Christiane, Kahan, Zsuzsanna, Gil-Gil, Miguel
Published in European journal of cancer (1990) (01.06.2022)
Published in European journal of cancer (1990) (01.06.2022)
Get full text
Journal Article
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
André, Thierry, Falcone, Alfredo, Shparyk, Yaroslav, Moiseenko, Fedor, Polo-Marques, Eduardo, Csöszi, Tibor, Campos-Bragagnoli, Arinilda, Liposits, Gabor, Chmielowska, Ewa, Aubel, Paul, Martín, Lourdes, Fougeray, Ronan, Amellal, Nadia, Saunders, Mark P
Published in The lancet. Gastroenterology & hepatology (01.02.2023)
Published in The lancet. Gastroenterology & hepatology (01.02.2023)
Get more information
Journal Article
Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2
Pritchard, Kathleen I, Burris, Howard A, Ito, Yoshinori, Rugo, Hope S, Dakhil, Shaker, Hortobagyi, Gabriel N, Campone, Mario, Csöszi, Tibor, Baselga, José, Puttawibul, Puttisak, Piccart, Martine, Heng, Daniel, Noguchi, Shinzaburo, Srimuninnimit, Vichien, Bourgeois, Hugues, Gonzalez Martin, Antonio, Osborne, Karen, Panneerselvam, Ashok, Taran, Tetiana, Sahmoud, Tarek, Gnant, Michael
Published in Clinical breast cancer (01.12.2013)
Published in Clinical breast cancer (01.12.2013)
Get full text
Journal Article
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial
Vogelzang, Nicholas J, Beer, Tomasz M, Gerritsen, Winald, Oudard, Stéphane, Wiechno, Pawel, Kukielka-Budny, Bozena, Samal, Vladimir, Hajek, Jaroslav, Feyerabend, Susan, Khoo, Vincent, Stenzl, Arnulf, Csöszi, Tibor, Filipovic, Zoran, Goncalves, Frederico, Prokhorov, Alexander, Cheung, Eric, Hussain, Arif, Sousa, Nuno, Bahl, Amit, Hussain, Syed, Fricke, Harald, Kadlecova, Pavla, Scheiner, Tomas, Korolkiewicz, Roman P, Bartunkova, Jirina, Spisek, Radek
Published in JAMA oncology (01.04.2022)
Published in JAMA oncology (01.04.2022)
Get more information
Journal Article
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O’Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leiby, Melanie A, Lubiniecki, Gregory M, Shentu, Yue, Rangwala, Reshma, Brahmer, Julie R
Published in The New England journal of medicine (10.11.2016)
Published in The New England journal of medicine (10.11.2016)
Get full text
Journal Article
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
Karthaus, Meinolf, Tibor, Csőszi, Lorusso, Vito, Singh-Arora, Rajender, Filippov, Alexander, Rizzi, Giada, Borroni, Maria Elisa, Rossi, Giorgia, Grunberg, Steven M.
Published in Supportive care in cancer (01.10.2015)
Published in Supportive care in cancer (01.10.2015)
Get full text
Journal Article
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A, Riess, Jonathan W, Jensen, Erin, Zhao, Bin, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Rudin, Charles M, Awad, Mark M, Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K, Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J, Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P, Luo, Yiwen, Ebiana, Victoria, Pietanza, M Catherine, Kim, Hye Ryun
Published in Journal of clinical oncology (20.07.2020)
Published in Journal of clinical oncology (20.07.2020)
Get full text
Journal Article
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Felip, Enriqueta, Altorki, Nasser, Zhou, Caicun, Csőszi, Tibor, Vynnychenko, Ihor, Goloborodko, Oleksandr, Luft, Alexander, Akopov, Andrey, Martinez-Marti, Alex, Kenmotsu, Hirotsugu, Chen, Yuh-Min, Chella, Antonio, Sugawara, Shunichi, Voong, David, Wu, Fan, Yi, Jing, Deng, Yu, McCleland, Mark, Bennett, Elizabeth, Gitlitz, Barbara, Wakelee, Heather
Published in The Lancet (British edition) (09.10.2021)
Published in The Lancet (British edition) (09.10.2021)
Get full text
Journal Article
OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)
Owonikoko, Taofeek, Nackaerts, Kristiaan, Csoszi, Tibor, Ostoros, Gyula, Baik, Christina, Ullmann, Claudio Dansky, Zagadailov, Erin, Sheldon-Waniga, Emily, Huebner, Dirk, Leonard, E Jane, Spigel, David
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Vandormael, Kristel, Riccio, Antonio, Yang, Jing, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
Paz-Ares, Luis, Luft, Alexander, Vicente, David, Tafreshi, Ali, Gümüş, Mahmut, Mazières, Julien, Hermes, Barbara, Çay Şenler, Filiz, Csőszi, Tibor, Fülöp, Andrea, Rodríguez-Cid, Jerónimo, Wilson, Jonathan, Sugawara, Shunichi, Kato, Terufumi, Lee, Ki Hyeong, Cheng, Ying, Novello, Silvia, Halmos, Balazs, Li, Xiaodong, Lubiniecki, Gregory M, Piperdi, Bilal, Kowalski, Dariusz M
Published in The New England journal of medicine (22.11.2018)
Published in The New England journal of medicine (22.11.2018)
Get full text
Journal Article
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Brahmer, Julie R, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Zhang, Jin, Lubiniecki, Gregory M, Deitz, Anne C, Rangwala, Reshma, Reck, Martin
Published in The lancet oncology (01.12.2017)
Published in The lancet oncology (01.12.2017)
Get full text
Journal Article
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial
Di Leo, Angelo, Johnston, Stephen, Lee, Keun Seok, Ciruelos, Eva, Lønning, Per E, Janni, Wolfgang, O'Regan, Ruth, Mouret-Reynier, Marie-Ange, Kalev, Dimitar, Egle, Daniel, Csőszi, Tibor, Bordonaro, Roberto, Decker, Thomas, Tjan-Heijnen, Vivianne C G, Blau, Sibel, Schirone, Alessio, Weber, Denis, El-Hashimy, Mona, Dharan, Bharani, Sellami, Dalila, Bachelot, Thomas
Published in The lancet oncology (01.01.2018)
Published in The lancet oncology (01.01.2018)
Get full text
Journal Article
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
Dasari, Arvind, Lonardi, Sara, Garcia-Carbonero, Rocio, Elez, Elena, Yoshino, Takayuki, Sobrero, Alberto, Yao, James, García-Alfonso, Pilar, Kocsis, Judit, Cubillo Gracian, Antonio, Sartore-Bianchi, Andrea, Satoh, Taroh, Randrian, Violaine, Tomasek, Jiri, Chong, Geoff, Paulson, Andrew Scott, Masuishi, Toshiki, Jones, Jeremy, Csőszi, Tibor, Cremolini, Chiara, Ghiringhelli, Francois, Shergill, Ardaman, Hochster, Howard S, Krauss, John, Bassam, Ali, Ducreux, Michel, Elme, Anneli, Faugeras, Laurence, Kasper, Stefan, Van Cutsem, Eric, Arnold, Dirk, Nanda, Shivani, Yang, Zhao, Schelman, William R, Kania, Marek, Tabernero, Josep, Eng, Cathy
Published in The Lancet (British edition) (01.07.2023)
Published in The Lancet (British edition) (01.07.2023)
Get full text
Journal Article
Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
Dómine Gómez, Manuel, Csőszi, Tibor, Jaal, Jana, Kudaba, Iveta, Nikolov, Krasimir, Radosavljevic, Davorin, Xiao, Jie, Horton, Janet K., Malik, Rajesh K., Subramanian, Janakiraman
Published in International journal of cancer (01.10.2021)
Published in International journal of cancer (01.10.2021)
Get full text
Journal Article
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
Yang, James Chih-Hsin, Han, Baohui, De La Mora Jiménez, Emmanuel, Lee, Jong-Seok, Koralewski, Piotr, Karadurmus, Nuri, Sugawara, Shunichi, Livi, Lorenzo, Basappa, Naveen S., Quantin, Xavier, Dudnik, Julia, Ortiz, Diego Moran, Mekhail, Tarek, Okpara, Chinyere E., Dutcus, Corina, Zimmer, Zachary, Samkari, Ayman, Bhagwati, Niyati, Csőszi, Tibor
Published in Journal of thoracic oncology (01.06.2024)
Published in Journal of thoracic oncology (01.06.2024)
Get full text
Journal Article